EPO Patents = 1

Trademarks = 2

Forward Citations = 21

Loading Chart...

6 inventors (with patents filed for the assignee):

Thomas Claiborne Lovelace (4 out of 6 patents)

Joseph Alexander Moore, Iii (4 out of 8 patents)

Christopher McKinnon Lee (4 out of 4 patents)

4. Daniel Logan Kirschner (4 out of 4 patents)

5. Alexander Smith (3 out of 17 patents)

6. Rostislav Christov Raykov (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12311026 - Therapeutic uses for sodium thiosulfate formulations (2025-05-27),

2. 11998604 - Therapeutic uses for sodium thiosulfate formulations (2024-06-04),

3. 11964018 - Therapeutic uses for sodium thiosulfate formulations (2024-04-23),

4. 11617793 - Anhydrous sodium thiosulfate and formulations thereof (2023-04-04),

5. 11510984 - Anhydrous sodium thiosulfate and formulations thereof (2022-11-29),

6. 11291728 - Anhydrous sodium thiosulfate and formulations thereof (2022-04-05),

7. 10792363 - Anhydrous sodium thiosulfate and formulations thereof (2020-10-06),

Company Overview

Fennec Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate) for the prevention of ototoxicity associated with cisplatin chemotherapy in pediatric patients. The company is dedicated to improving the lives of children undergoing cancer treatment by providing safe and effective therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#36 in Research Triangle Park, NC

#857 in North Carolina

#39,907 in US

Research Triangle Park, NC, United States of America

Fennec Pharmaceuticals, Inc.

Forward Citations = 21

6 inventors:

Thomas Claiborne Lovelace (4 out of 6 patents)

Joseph Alexander Moore, Iii (4 out of 8 patents)

Christopher McKinnon Lee (4 out of 4 patents)

4. Daniel Logan Kirschner (4 out of 4 patents)

5. Alexander Smith (3 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fennec Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/fennec-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]